abstract |
The present invention is a novel 3-phenyl-3-methoxy-pyrrolidine useful for the regulation of extracellular levels of catecholamines, dopamine and norepinephrine in the cerebral cortical region of the mammalian brain, more particularly useful for the treatment of central nervous system disorders. To derivatives. In another aspect, the present invention relates to pharmaceutical compositions comprising the 3-phenyl-3-methoxy-pyrrolidine derivatives of the present invention and to the use of these compounds in therapeutic applications. |